{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:36:56Z","timestamp":1779100616087,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1208\/s12248-016-9945-7","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T13:01:51Z","timestamp":1466686911000},"page":"1273-1288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Metabolic Profile of 3-Acetyl-11-Keto-\u03b2-Boswellic Acid and 11-Keto-\u03b2-Boswellic Acid in Human Preparations In Vitro, Species Differences, and Bioactivity Variation"],"prefix":"10.1208","volume":"18","author":[{"given":"Yonglei","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangge","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenlong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokui","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baojing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,21]]},"reference":[{"issue":"4","key":"9945_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4103\/2225-4110.119723","volume":"3","author":"R Hamidpour","year":"2013","unstructured":"Hamidpour R, Hamidpour S, Hamidpour M, Shahlari M. Frankincense (ru xiang; boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. J Tradit Complement Med. 2013;3(4):221\u20136. doi: 10.4103\/2225-4110.119723 .","journal-title":"J Tradit Complement Med"},{"issue":"6-7","key":"9945_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.phymed.2007.11.019","volume":"15","author":"S Singh","year":"2008","unstructured":"Singh S, Khajuria A, Taneja SC, Johri RK, Singh J, Qazi GN. Boswellic acids: a leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine. 2008;15(6-7):400\u20137. doi: 10.1016\/j.phymed.2007.11.019 .","journal-title":"Phytomedicine"},{"issue":"6","key":"9945_CR3","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1016\/j.bbagen.2013.03.003","volume":"1830","author":"YS Zhang","year":"2013","unstructured":"Zhang YS, Xie JZ, Zhong JL, Li YY, Wang RQ, Qin YZ, et al. Acetyl-11-keto-beta-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt\/beta-catenin signaling pathway. Biochim Biophys Acta. 2013;1830(6):3604\u201315. doi: 10.1016\/j.bbagen.2013.03.003 .","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"9945_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.foodchem.2004.08.033","volume":"92","author":"AN Assimopoulou","year":"2005","unstructured":"Assimopoulou AN, Zlatanos SN, Papageorgiou VP. Antioxidant activity of natural resins and bioactive triterpenes in oil substrates. Food Chem. 2005;92(4):721\u20137. doi: 10.1016\/j.foodchem.2004.08.0333 .","journal-title":"Food Chem"},{"key":"9945_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/1756-0500-4-406","volume":"4","author":"AF Raja","year":"2011","unstructured":"Raja AF, Ali F, Khan IA, Shawl AS, Arora DS. Acetyl-11-keto-beta-boswellic acid (AKBA); targeting oral cavity pathogens. BMC Res Notes. 2011;4:406. doi: 10.1186\/1756-0500-4-406 .","journal-title":"BMC Res Notes"},{"key":"9945_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2180-11-54","volume":"11","author":"AF Raja","year":"2011","unstructured":"Raja AF, Ali F, Khan IA, Shawl AS, Arora DS, Shah BA, et al. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-beta-boswellic acid from Boswellia serrata. BMC Microbiol. 2011;11:54. doi: 10.1186\/1471-2180-11-54 .","journal-title":"BMC Microbiol"},{"issue":"28","key":"9945_CR7","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.2174\/092986706779010333","volume":"13","author":"D Poeckel","year":"2006","unstructured":"Poeckel D, Werz O. Boswellic acids: biological actions and molecular targets. Curr Med Chem. 2006;13(28):3359\u201369.","journal-title":"Curr Med Chem"},{"key":"9945_CR8","doi-asserted-by":"publisher","first-page":"a2813","DOI":"10.1136\/bmj.a2813","volume":"337","author":"E Ernst","year":"2008","unstructured":"Ernst E. Frankincense: systematic review. BMJ. 2008;337:a2813. doi: 10.1136\/bmj.a2813 .","journal-title":"BMJ"},{"issue":"1","key":"9945_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1055\/s-2001-10708","volume":"39","author":"H Gerhardt","year":"2001","unstructured":"Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Therapy of active Crohn disease with Boswellia serrata extract H 15. Z Gastroenterol. 2001;39(1):11\u20137. doi: 10.1055\/s-2001-10708 .","journal-title":"Z Gastroenterol"},{"issue":"1","key":"9945_CR10","first-page":"37","volume":"2","author":"I Gupta","year":"1997","unstructured":"Gupta I, Parihar A, Malhotra P, Singh GB, Ludtke R, Safayhi H, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. 1997;2(1):37\u201343.","journal-title":"Eur J Med Res"},{"issue":"2","key":"9945_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1161\/ATVBAHA.107.155606","volume":"28","author":"C Cuaz-Perolin","year":"2008","unstructured":"Cuaz-Perolin C, Billiet L, Bauge E, Copin C, Scott-Algara D, Genze F, et al. Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-\/- mice. Arterioscler Thromb Vasc Biol. 2008;28(2):272\u20137. doi: 10.1161\/ATVBAHA.107.155606 .","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"9945_CR12","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.4049\/jimmunol.176.5.3127","volume":"176","author":"Y Takada","year":"2006","unstructured":"Takada Y, Ichikawa H, Badmaev V, Aggarwal BB. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. 2006;176(5):3127\u201340.","journal-title":"J Immunol"},{"issue":"2","key":"9945_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.bjp.0705604","volume":"141","author":"A Altmann","year":"2004","unstructured":"Altmann A, Poeckel D, Fischer L, Schubert-Zsilavecz M, Steinhilber D, Werz O. Coupling of boswellic acid-induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes. Br J Pharmacol. 2004;141(2):223\u201332. doi: 10.1038\/sj.bjp.0705604 .","journal-title":"Br J Pharmacol"},{"issue":"4","key":"9945_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1476-5381.1996.tb15235.x","volume":"117","author":"ER Sailer","year":"1996","unstructured":"Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HP, Safayhi H. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol. 1996;117(4):615\u20138.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"9945_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1124\/mol.106.024836","volume":"70","author":"D Poeckel","year":"2006","unstructured":"Poeckel D, Tausch L, Kather N, Jauch J, Werz O. Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase. Mol Pharmacol. 2006;70(3):1071\u20138. doi: 10.1124\/mol.106.024836 .","journal-title":"Mol Pharmacol"},{"issue":"1","key":"9945_CR16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-3565(24)36628-5","volume":"281","author":"H Safayhi","year":"1997","unstructured":"Safayhi H, Rall B, Sailer ER, Ammon HP. Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther. 1997;281(1):460\u20133.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"9945_CR17","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.4049\/jimmunol.0803574","volume":"183","author":"L Tausch","year":"2009","unstructured":"Tausch L, Henkel A, Siemoneit U, Poeckel D, Kather N, Franke L, et al. Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense. J Immunol. 2009;183(5):3433\u201342. doi: 10.4049\/jimmunol.0803574 .","journal-title":"J Immunol"},{"issue":"1","key":"9945_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1476-5381.2010.01020.x","volume":"162","author":"U Siemoneit","year":"2011","unstructured":"Siemoneit U, Koeberle A, Rossi A, Dehm F, Verhoff M, Reckel S, et al. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. Br J Pharmacol. 2011;162(1):147\u201362. doi: 10.1111\/j.1476-5381.2010.01020.x .","journal-title":"Br J Pharmacol"},{"issue":"2","key":"9945_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bcp.2007.09.010","volume":"75","author":"U Siemoneit","year":"2008","unstructured":"Siemoneit U, Hofmann B, Kather N, Lamkemeyer T, Madlung J, Franke L, et al. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids. Biochem Pharmacol. 2008;75(2):503\u201313. doi: 10.1016\/j.bcp.2007.09.010 .","journal-title":"Biochem Pharmacol"},{"issue":"17","key":"9945_CR20","doi-asserted-by":"publisher","first-page":"12717","DOI":"10.1039\/C4RA16459H","volume":"5","author":"C Wang","year":"2015","unstructured":"Wang C, Dong PP, Zhang LY, Huo XK, Zhang BJ, Wang CY, et al. Regio- and stereo-selective oxidation of beta-boswellic acids transformed by filamentous fungi. RSC Adv. 2015;5(17):12717\u201325. doi: 10.1039\/c4ra16459h .","journal-title":"RSC Adv"},{"key":"9945_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.phytochem.2013.07.018","volume":"96","author":"Y Wang","year":"2013","unstructured":"Wang Y, Sun Y, Wang C, Huo X, Liu P, Wang C, et al. Biotransformation of 11-keto-beta-boswellic acid by Cunninghamella blakesleana. Phytochemistry. 2013;96:330\u20136. doi: 10.1016\/j.phytochem.2013.07.018 .","journal-title":"Phytochemistry"},{"issue":"5","key":"9945_CR22","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bmcl.2012.12.086","volume":"23","author":"Y Sun","year":"2013","unstructured":"Sun Y, Liu D, Xi R, Wang X, Wang Y, Hou J, et al. Microbial transformation of acetyl-11-keto-beta-boswellic acid and their inhibitory activity on LPS-induced NO production. Bioorg Med Chem Lett. 2013;23(5):1338\u201342. doi: 10.1016\/j.bmcl.2012.12.086 .","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"9945_CR23","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00253-011-3467-0","volume":"93","author":"S Bleif","year":"2012","unstructured":"Bleif S, Hannemann F, Zapp J, Hartmann D, Jauch J, Bernhardt R. A new Bacillus megaterium whole-cell catalyst for the hydroxylation of the pentacyclic triterpene 11-keto-beta-boswellic acid (KBA) based on a recombinant cytochrome P450 system. Appl Microbiol Biotechnol. 2012;93(3):1135\u201346. doi: 10.1007\/s00253-011-3467-0 .","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"9945_CR24","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00253-013-5029-0","volume":"98","author":"E Brill","year":"2014","unstructured":"Brill E, Hannemann F, Zapp J, Bruning G, Jauch J, Bernhardt R. A new cytochrome P450 system from Bacillus megaterium DSM319 for the hydroxylation of 11-keto-beta-boswellic acid (KBA). Appl Microbiol Biotechnol. 2014;98(4):1701\u201317. doi: 10.1007\/s00253-013-5029-0 .","journal-title":"Appl Microbiol Biotechnol"},{"key":"9945_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.fitote.2012.10.009","volume":"84","author":"K Gerbeth","year":"2013","unstructured":"Gerbeth K, Husch J, Fricker G, Werz O, Schubert-Zsilavecz M, Abdel-Tawab M. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins. Fitoterapia. 2013;84:99\u2013106. doi: 10.1016\/j.fitote.2012.10.009 .","journal-title":"Fitoterapia"},{"issue":"2","key":"9945_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1570-0232(03)00555-5","volume":"795","author":"B Buchele","year":"2003","unstructured":"Buchele B, Simmet T. Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;795(2):355\u201362.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6","key":"9945_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2165\/11586800-000000000-00000","volume":"50","author":"M Abdel-Tawab","year":"2011","unstructured":"Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 2011;50(6):349\u201369. doi: 10.2165\/11586800-000000000-00000 .","journal-title":"Clin Pharmacokinet"},{"issue":"2-3","key":"9945_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1078\/0944-7113-00290","volume":"11","author":"S Sharma","year":"2004","unstructured":"Sharma S, Thawani V, Hingorani L, Shrivastava M, Bhate VR, Khiyani R. Pharmacokinetic study of 11-Keto beta-Boswellic acid. Phytomedicine. 2004;11(2-3):255\u201360.","journal-title":"Phytomedicine"},{"issue":"6","key":"9945_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1124\/dmd.107.018424","volume":"36","author":"P Kruger","year":"2008","unstructured":"Kruger P, Daneshfar R, Eckert GP, Klein J, Volmer DA, Bahr U, et al. Metabolism of boswellic acids in vitro and in vivo. Drug Metab Dispos: Biol Fate Chem. 2008;36(6):1135\u201342. doi: 10.1124\/dmd.107.018424 .","journal-title":"Drug Metab Dispos: Biol Fate Chem"},{"issue":"6","key":"9945_CR30","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1021\/bc0155420","volume":"12","author":"PD Senter","year":"2001","unstructured":"Senter PD, Beam KS, Mixan B, Wahl AF. Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug. Bioconjug Chem. 2001;12(6):1074\u201380.","journal-title":"Bioconjug Chem"},{"issue":"5","key":"9945_CR31","first-page":"1189","volume":"60","author":"R Humerickhouse","year":"2000","unstructured":"Humerickhouse R, Lohrbach K, Li L, Bosron WF, Dolan ME. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2. Cancer Res. 2000;60(5):1189\u201392.","journal-title":"Cancer Res"},{"issue":"1","key":"9945_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.dmpk.2014.12.001","volume":"30","author":"S Oda","year":"2015","unstructured":"Oda S, Fukami T, Yokoi T, Nakajima M. A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development. Drug Metab Pharmacokinet. 2015;30(1):30\u201351. doi: 10.1016\/j.dmpk.2014.12.001 .","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"9945_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1582-4934.2002.tb00186.x","volume":"6","author":"R Zuber","year":"2002","unstructured":"Zuber R, Anzenbacherova E, Anzenbacher P. Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med. 2002;6(2):189\u201398.","journal-title":"J Cell Mol Med"},{"key":"9945_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev.pharmtox.38.1.389","volume":"38","author":"KE Thummel","year":"1998","unstructured":"Thummel KE, Wilkinson GR. In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol. 1998;38:389\u2013430. doi: 10.1146\/annurev.pharmtox.38.1.389 .","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9945_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","volume":"39","author":"FP Guengerich","year":"1999","unstructured":"Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol. 1999;39:1\u201317. doi: 10.1146\/annurev.pharmtox.39.1.1 .","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"9945_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1124\/jpet.105.086504","volume":"314","author":"JS Leeder","year":"2005","unstructured":"Leeder JS, Gaedigk R, Marcucci KA, Gaedigk A, Vyhlidal CA, Schindel BP, et al. Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther. 2005;314(2):626\u201335. doi: 10.1124\/jpet.105.086504 .","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"9945_CR37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/mol.59.2.386","volume":"59","author":"TL Domanski","year":"2001","unstructured":"Domanski TL, Finta C, Halpert JR, Zaphiropoulos PG. cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. Mol Pharmacol. 2001;59(2):386\u201392.","journal-title":"Mol Pharmacol"},{"issue":"6","key":"9945_CR38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/17425255.2.6.875","volume":"2","author":"M Martignoni","year":"2006","unstructured":"Martignoni M, Groothuis GM, de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol. 2006;2(6):875\u201394. doi: 10.1517\/17425255.2.6.875 .","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"9945_CR39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/BF00293631","volume":"62","author":"Z Grubic","year":"1988","unstructured":"Grubic Z, Sket D, Brzin M. Iso-OMPA-induced potentiation of soman toxicity in rat correlates with the inhibition of plasma carboxylesterases. Arch Toxicol. 1988;62(5):398\u20139.","journal-title":"Arch Toxicol"},{"key":"9945_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bios.2014.10.002","volume":"65C","author":"L Feng","year":"2014","unstructured":"Feng L, Liu ZM, Hou J, Lv X, Ning J, Ge GB, et al. A highly selective fluorescent ESIPT probe for the detection of human carboxylesterase 2 and its biological applications. Biosens Bioelectron. 2014;65C:9\u201315. doi: 10.1016\/j.bios.2014.10.002 .","journal-title":"Biosens Bioelectron"},{"issue":"8","key":"9945_CR41","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1124\/dmd.115.064089","volume":"43","author":"T Kurokawa","year":"2015","unstructured":"Kurokawa T, Fukami T, Nakajima M. Characterization of species differences in tissue diltiazem deacetylation identifies Ces2a as a rat-specific diltiazem deacetylase. Drug Metab Dispos: Biol Fate Chem. 2015;43(8):1218\u201325. doi: 10.1124\/dmd.115.064089 .","journal-title":"Drug Metab Dispos: Biol Fate Chem"},{"issue":"1","key":"9945_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1208\/s12248-014-9658-8","volume":"17","author":"X Tian","year":"2015","unstructured":"Tian X, Liang S, Wang C, Wu B, Ge G, Deng S, et al. Regioselective glucuronidation of andrographolide and its major derivatives: metabolite identification, isozyme contribution, and species differences. AAPS J. 2015;17(1):156\u201366. doi: 10.1208\/s12248-014-9658-8 .","journal-title":"AAPS J"},{"issue":"3","key":"9945_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1124\/dmd.114.060996","volume":"43","author":"J Ning","year":"2015","unstructured":"Ning J, Yu ZL, Hu LH, Wang C, Huo XK, Deng S, et al. Characterization of phase I metabolism of resibufogenin and evaluation of the metabolic effects on its antitumor activity and toxicity. Drug Metab Dispos: Biol Fate Chem. 2015;43(3):299\u2013308. doi: 10.1124\/dmd.114.060996 .","journal-title":"Drug Metab Dispos: Biol Fate Chem"},{"issue":"1","key":"9945_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.toxlet.2014.08.004","volume":"230","author":"J Dinger","year":"2014","unstructured":"Dinger J, Meyer MR, Maurer HH. Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse. Toxicol Lett. 2014;230(1):28\u201335. doi: 10.1016\/j.toxlet.2014.08.004 .","journal-title":"Toxicol Lett"},{"issue":"9","key":"9945_CR45","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1124\/dmd.112.045302","volume":"40","author":"RL Walsky","year":"2012","unstructured":"Walsky RL, Obach RS, Hyland R, Kang P, Zhou S, West M, et al. Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs. Drug Metab Dispos: Biol Fate Chem. 2012;40(9):1686\u201397. doi: 10.1124\/dmd.112.045302 .","journal-title":"Drug Metab Dispos: Biol Fate Chem"},{"issue":"84","key":"9945_CR46","doi-asserted-by":"publisher","first-page":"9779","DOI":"10.1039\/c3cc45250f","volume":"49","author":"GB Ge","year":"2013","unstructured":"Ge GB, Ning J, Hu LH, Dai ZR, Hou J, Cao YF, et al. A highly selective probe for human cytochrome P450 3A4: isoform selectivity, kinetic characterization and its applications. Chem Commun. 2013;49(84):9779\u201381. doi: 10.1039\/c3cc45250f .","journal-title":"Chem Commun"},{"issue":"3","key":"9945_CR47","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1124\/dmd.111.042192","volume":"40","author":"L Zhu","year":"2012","unstructured":"Zhu L, Ge G, Zhang H, Liu H, He G, Liang S, et al. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms. Drug Metab Dispos: Biol Fate Chem. 2012;40(3):529\u201338. doi: 10.1124\/dmd.111.042192 .","journal-title":"Drug Metab Dispos: Biol Fate Chem"},{"key":"9945_CR48","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1476-4598-13-203","volume":"13","author":"Z Yu","year":"2014","unstructured":"Yu Z, Guo W, Ma X, Zhang B, Dong P, Huang L, et al. Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKbeta\/NF-kappaB signaling pathway in lung cancer cells. Mol Cancer. 2014;13:203. doi: 10.1186\/1476-4598-13-203 .","journal-title":"Mol Cancer"}],"updated-by":[{"DOI":"10.1208\/s12248-019-0371-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000}}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-016-9945-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-016-9945-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-016-9945-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-016-9945-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T22:32:37Z","timestamp":1748989957000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-016-9945-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,21]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9945"],"URL":"https:\/\/doi.org\/10.1208\/s12248-016-9945-7","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,21]]},"assertion":[{"value":"25 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}